Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.

Australia Hallucinogens / pharmacology Humans Lysergic Acid Diethylamide Mental Health Psilocybin / pharmacology
LSD MDMA Psychedelic-assisted psychotherapy ayahuasca depression mental disorders neuroscience post-traumatic stress disorder psilocybin psychiatry

Journal

The Australian and New Zealand journal of psychiatry
ISSN: 1440-1614
Titre abrégé: Aust N Z J Psychiatry
Pays: England
ID NLM: 0111052

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 23 3 2021
medline: 15 12 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

The medical use of psychedelic substances (e.g. psilocybin, ayahuasca, lysergic acid diethylamide and 3,4-methylenedioxymethamphetamine) is attracting renewed interest, driven by a pressing need for research and development of novel therapies for psychiatric disorders, as well as promising results of contemporary studies. In this Viewpoint, we reflect upon the 'Clinical Memorandum on Psychedelics' recently released by the

Identifiants

DOI: 10.1177/0004867421998785 PMID: 33745287
pubmed: 33745287
doi: 10.1177/0004867421998785
doi:

Substances chimiques

Hallucinogens 0
Psilocybin 2RV7212BP0
Lysergic Acid Diethylamide 8NA5SWF92O

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1127-1133

Auteurs

Daniel Perkins (D)

School of Social and Political Science, The University of Melbourne, Parkville, VIC, Australia.
ORCID: 0000-0002-2055-1649

Jerome Sarris (J)

NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia.
Professorial Unit, The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.
ORCID: 0000-0001-9287-8854

Susan Rossell (S)

Centre for Mental Health, Swinburne University, Hawthorn, VIC, Australia.
Department of Psychiatry, St Vincent's Hospital, Fitzroy, VIC, Australia.
ORCID: 0000-0002-7415-8252

Yvonne Bonomo (Y)

Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
Department of Addiction, St Vincent's Hospital, Melbourne, VIC, Australia.

David Forbes (D)

Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.

Christopher Davey (C)

Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.

Daniel Hoyer (D)

Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, VIC, Australia.
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.

Colleen Loo (C)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Black Dog Institute, Sydney, NSW, Australia.
ORCID: 0000-0003-3267-0554

Greg Murray (G)

Centre for Mental Health, Swinburne University, Hawthorn, VIC, Australia.

Sean Hood (S)

Division of Psychiatry, UWA Medical School, Faculty of Health & Medical Sciences, The University of Western Australia, Perth, WA, Australia.
ORCID: 0000-0003-2852-7923

Violeta Schubert (V)

School of Social and Political Science, The University of Melbourne, Parkville, VIC, Australia.

Nicole Leite Galvão-Coelho (NL)

Department of Physiology and Behavior, Federal University of Rio Grande do Norte, Natal, Brazil.

Meaghen O'Donnell (M)

Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.

Olivia Carter (O)

Melbourne School of Psychological Science, The University of Melbourne, Melbourne, VIC, Australia.

Paul Liknaitzky (P)

Turner Institute, School of Psychological Sciences, Monash University, Clayton, VIC, Australia.
Dept of Psychiatry, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
ORCID: 0000-0001-5690-2263

Martin Williams (M)

Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Dan Siskind (D)

Mobile Intensive Rehabilitation Team, Metro South Addiction and Mental Health Service, Brisbane, QLD, Australia.
School of Clinical Medicine, University of Queensland, Brisbane, QLD, Australia.
ORCID: 0000-0002-2072-9216

David Penington (D)

Vice-Chancellor's Office, The University of Melbourne, Melbourne, VIC, Australia.

Michael Berk (M)

Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.
School of Medicine, IMPACT Research Institute, Deakin University, Geelong, VIC, Australia.
Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
Orygen The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
ORCID: 0000-0002-5554-6946

David Castle (D)

Scientific Director, Centre for Complex Interventions, Centre for Addictions and Mental Health; and Professor, Department of Psychiatry, University of Toronto, Toronto, Canada.
ORCID: 0000-0002-3075-1580

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Medicinal psychedelics for mental health and...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Psychoanaleptiques › Hallucinogènes › Medicinal psychedelics for mental health and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Medicinal psychedelics for mental health and...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérocycliques avec 4 noyaux ou plus › Ergolines › Acide lysergique › Lysergide › Medicinal psychedelics for mental health and...
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé mentale › Medicinal psychedelics for mental health and...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Indolizine › Indolizidines › Alcaloïdes indoliques › Psilocybine › Medicinal psychedelics for mental health and...